Market Executive Summary
The global market for Patent Drug was estimated to be worth US$ 1175150 million in 2024 and is forecast to a readjusted size of US$ 1645690 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
A patent medicine is typically protected and advertised by a trademark and trade name (and sometimes a patent) and claimed to be effective against minor disorders and symptoms.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Patent Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Patent Drug by region & country, by Type, and by Application.
The Patent Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Patent Drug.
Global Patent Drug Companies Covered
Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences, GlaxoSmithKline (GSK), Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Teva, Bayer, Novo Nordisk, AbbVie, Takeda, Boehringer Ingelheim, Takeda
Global Patent Drug Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Patent Drug Market, Segment by Type
Oral
Injection
Other
Global Patent Drug Market, Segment by Application
Hospital
Retail Pharmacy
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Patent Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Patent Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Patent Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Related Report:
Global Drug Discovery Assays Market Size, Share, Competitive Analysis, Key Players, Growth Drivers, Trends, Opportunities, Revenue Analysis, and Demand Forecast to 2032
Global Antibody-drug Conjugates Market Size, Share, Opportunities, Competitive Landscape, Key Players, Growth Drivers, Trends, Revenue Analysis, and Demand Forecast to 2032
Table of Contents
Table of Contents
1 Market Overview
1.1 Patent Drug Product Introduction
1.2 Global Patent Drug Market Size Forecast (2020-2031)
1.3 Patent Drug Market Trends & Drivers
1.3.1 Patent Drug Industry Trends
1.3.2 Patent Drug Market Drivers & Opportunity
1.3.3 Patent Drug Market Challenges
1.3.4 Patent Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Patent Drug Players Revenue Ranking (2024)
2.2 Global Patent Drug Revenue by Company (2020-2025)
2.3 Key Companies Patent Drug Manufacturing Base Distribution and Headquarters
2.4 Key Companies Patent Drug Product Offered
2.5 Key Companies Time to Begin Mass Production of Patent Drug
2.6 Patent Drug Market Competitive Analysis
2.6.1 Patent Drug Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Patent Drug Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Drug as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Injection
3.1.3 Other
3.2 Global Patent Drug Sales Value by Type
3.2.1 Global Patent Drug Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Patent Drug Sales Value, by Type (2020-2031)
3.2.3 Global Patent Drug Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Retail Pharmacy
4.2 Global Patent Drug Sales Value by Application
4.2.1 Global Patent Drug Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Patent Drug Sales Value, by Application (2020-2031)
4.2.3 Global Patent Drug Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Patent Drug Sales Value by Region
5.1.1 Global Patent Drug Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Patent Drug Sales Value by Region (2020-2025)
5.1.3 Global Patent Drug Sales Value by Region (2026-2031)
5.1.4 Global Patent Drug Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Patent Drug Sales Value, 2020-2031
5.2.2 North America Patent Drug Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Patent Drug Sales Value, 2020-2031
5.3.2 Europe Patent Drug Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Patent Drug Sales Value, 2020-2031
5.4.2 Asia Pacific Patent Drug Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Patent Drug Sales Value, 2020-2031
5.5.2 South America Patent Drug Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Patent Drug Sales Value, 2020-2031
5.6.2 Middle East & Africa Patent Drug Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Patent Drug Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Patent Drug Sales Value, 2020-2031
6.3 United States
6.3.1 United States Patent Drug Sales Value, 2020-2031
6.3.2 United States Patent Drug Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Patent Drug Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Patent Drug Sales Value, 2020-2031
6.4.2 Europe Patent Drug Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Patent Drug Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Patent Drug Sales Value, 2020-2031
6.5.2 China Patent Drug Sales Value by Type (%), 2024 VS 2031
6.5.3 China Patent Drug Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Patent Drug Sales Value, 2020-2031
6.6.2 Japan Patent Drug Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Patent Drug Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Patent Drug Sales Value, 2020-2031
6.7.2 South Korea Patent Drug Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Patent Drug Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Patent Drug Sales Value, 2020-2031
6.8.2 Southeast Asia Patent Drug Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Patent Drug Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Patent Drug Sales Value, 2020-2031
6.9.2 India Patent Drug Sales Value by Type (%), 2024 VS 2031
6.9.3 India Patent Drug Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer Patent Drug Products, Services and Solutions
7.1.4 Pfizer Patent Drug Revenue (US$ Million) & (2020-2025)
7.1.5 Pfizer Recent Developments
7.2 Roche
7.2.1 Roche Profile
7.2.2 Roche Main Business
7.2.3 Roche Patent Drug Products, Services and Solutions
7.2.4 Roche Patent Drug Revenue (US$ Million) & (2020-2025)
7.2.5 Roche Recent Developments
7.3 Sanofi
7.3.1 Sanofi Profile
7.3.2 Sanofi Main Business
7.3.3 Sanofi Patent Drug Products, Services and Solutions
7.3.4 Sanofi Patent Drug Revenue (US$ Million) & (2020-2025)
7.3.5 Sanofi Recent Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Profile
7.4.2 Johnson & Johnson Main Business
7.4.3 Johnson & Johnson Patent Drug Products, Services and Solutions
7.4.4 Johnson & Johnson Patent Drug Revenue (US$ Million) & (2020-2025)
7.4.5 Johnson & Johnson Recent Developments
7.5 Merck & Co. (MSD)
7.5.1 Merck & Co. (MSD) Profile
7.5.2 Merck & Co. (MSD) Main Business
7.5.3 Merck & Co. (MSD) Patent Drug Products, Services and Solutions
7.5.4 Merck & Co. (MSD) Patent Drug Revenue (US$ Million) & (2020-2025)
7.5.5 Merck & Co. (MSD) Recent Developments
7.6 Novartis
7.6.1 Novartis Profile
7.6.2 Novartis Main Business
7.6.3 Novartis Patent Drug Products, Services and Solutions
7.6.4 Novartis Patent Drug Revenue (US$ Million) & (2020-2025)
7.6.5 Novartis Recent Developments
7.7 AbbVie
7.7.1 AbbVie Profile
7.7.2 AbbVie Main Business
7.7.3 AbbVie Patent Drug Products, Services and Solutions
7.7.4 AbbVie Patent Drug Revenue (US$ Million) & (2020-2025)
7.7.5 AbbVie Recent Developments
7.8 Gilead Sciences
7.8.1 Gilead Sciences Profile
7.8.2 Gilead Sciences Main Business
7.8.3 Gilead Sciences Patent Drug Products, Services and Solutions
7.8.4 Gilead Sciences Patent Drug Revenue (US$ Million) & (2020-2025)
7.8.5 Gilead Sciences Recent Developments
7.9 GlaxoSmithKline (GSK)
7.9.1 GlaxoSmithKline (GSK) Profile
7.9.2 GlaxoSmithKline (GSK) Main Business
7.9.3 GlaxoSmithKline (GSK) Patent Drug Products, Services and Solutions
7.9.4 GlaxoSmithKline (GSK) Patent Drug Revenue (US$ Million) & (2020-2025)
7.9.5 GlaxoSmithKline (GSK) Recent Developments
7.10 Amgen
7.10.1 Amgen Profile
7.10.2 Amgen Main Business
7.10.3 Amgen Patent Drug Products, Services and Solutions
7.10.4 Amgen Patent Drug Revenue (US$ Million) & (2020-2025)
7.10.5 Amgen Recent Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Profile
7.11.2 AstraZeneca Main Business
7.11.3 AstraZeneca Patent Drug Products, Services and Solutions
7.11.4 AstraZeneca Patent Drug Revenue (US$ Million) & (2020-2025)
7.11.5 AstraZeneca Recent Developments
7.12 Bristol-Myers Squibb
7.12.1 Bristol-Myers Squibb Profile
7.12.2 Bristol-Myers Squibb Main Business
7.12.3 Bristol-Myers Squibb Patent Drug Products, Services and Solutions
7.12.4 Bristol-Myers Squibb Patent Drug Revenue (US$ Million) & (2020-2025)
7.12.5 Bristol-Myers Squibb Recent Developments
7.13 Eli Lilly
7.13.1 Eli Lilly Profile
7.13.2 Eli Lilly Main Business
7.13.3 Eli Lilly Patent Drug Products, Services and Solutions
7.13.4 Eli Lilly Patent Drug Revenue (US$ Million) & (2020-2025)
7.13.5 Eli Lilly Recent Developments
7.14 Teva
7.14.1 Teva Profile
7.14.2 Teva Main Business
7.14.3 Teva Patent Drug Products, Services and Solutions
7.14.4 Teva Patent Drug Revenue (US$ Million) & (2020-2025)
7.14.5 Teva Recent Developments
7.15 Bayer
7.15.1 Bayer Profile
7.15.2 Bayer Main Business
7.15.3 Bayer Patent Drug Products, Services and Solutions
7.15.4 Bayer Patent Drug Revenue (US$ Million) & (2020-2025)
7.15.5 Bayer Recent Developments
7.16 Novo Nordisk
7.16.1 Novo Nordisk Profile
7.16.2 Novo Nordisk Main Business
7.16.3 Novo Nordisk Patent Drug Products, Services and Solutions
7.16.4 Novo Nordisk Patent Drug Revenue (US$ Million) & (2020-2025)
7.16.5 Novo Nordisk Recent Developments
7.17 AbbVie
7.17.1 AbbVie Profile
7.17.2 AbbVie Main Business
7.17.3 AbbVie Patent Drug Products, Services and Solutions
7.17.4 AbbVie Patent Drug Revenue (US$ Million) & (2020-2025)
7.17.5 AbbVie Recent Developments
7.18 Takeda
7.18.1 Takeda Profile
7.18.2 Takeda Main Business
7.18.3 Takeda Patent Drug Products, Services and Solutions
7.18.4 Takeda Patent Drug Revenue (US$ Million) & (2020-2025)
7.18.5 Takeda Recent Developments
7.19 Boehringer Ingelheim
7.19.1 Boehringer Ingelheim Profile
7.19.2 Boehringer Ingelheim Main Business
7.19.3 Boehringer Ingelheim Patent Drug Products, Services and Solutions
7.19.4 Boehringer Ingelheim Patent Drug Revenue (US$ Million) & (2020-2025)
7.19.5 Boehringer Ingelheim Recent Developments
7.20 Takeda
7.20.1 Takeda Profile
7.20.2 Takeda Main Business
7.20.3 Takeda Patent Drug Products, Services and Solutions
7.20.4 Takeda Patent Drug Revenue (US$ Million) & (2020-2025)
7.20.5 Takeda Recent Developments
8 Industry Chain Analysis
8.1 Patent Drug Industrial Chain
8.2 Patent Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Patent Drug Sales Model
8.5.2 Sales Channel
8.5.3 Patent Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Figures
Table of Figures
List of Tables
Table 1. Patent Drug Market Trends
Table 2. Patent Drug Market Drivers & Opportunity
Table 3. Patent Drug Market Challenges
Table 4. Patent Drug Market Restraints
Table 5. Global Patent Drug Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Patent Drug Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Patent Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Patent Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Patent Drug
Table 10. Global Patent Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Drug as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Patent Drug Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Patent Drug Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Patent Drug Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Patent Drug Sales Market Share in Value by Type (2020-2025)
Table 17. Global Patent Drug Sales Market Share in Value by Type (2026-2031)
Table 18. Global Patent Drug Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Patent Drug Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Patent Drug Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Patent Drug Sales Market Share in Value by Application (2020-2025)
Table 22. Global Patent Drug Sales Market Share in Value by Application (2026-2031)
Table 23. Global Patent Drug Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Patent Drug Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Patent Drug Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Patent Drug Sales Value by Region (2020-2025) & (%)
Table 27. Global Patent Drug Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Patent Drug Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Patent Drug Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Patent Drug Sales Value, (2026-2031) & (US$ Million)
Table 31. Pfizer Basic Information List
Table 32. Pfizer Description and Business Overview
Table 33. Pfizer Patent Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Patent Drug Business of Pfizer (2020-2025)
Table 35. Pfizer Recent Developments
Table 36. Roche Basic Information List
Table 37. Roche Description and Business Overview
Table 38. Roche Patent Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Patent Drug Business of Roche (2020-2025)
Table 40. Roche Recent Developments
Table 41. Sanofi Basic Information List
Table 42. Sanofi Description and Business Overview
Table 43. Sanofi Patent Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Patent Drug Business of Sanofi (2020-2025)
Table 45. Sanofi Recent Developments
Table 46. Johnson & Johnson Basic Information List
Table 47. Johnson & Johnson Description and Business Overview
Table 48. Johnson & Johnson Patent Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Patent Drug Business of Johnson & Johnson (2020-2025)
Table 50. Johnson & Johnson Recent Developments
Table 51. Merck & Co. (MSD) Basic Information List
Table 52. Merck & Co. (MSD) Description and Business Overview
Table 53. Merck & Co. (MSD) Patent Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Patent Drug Business of Merck & Co. (MSD) (2020-2025)
Table 55. Merck & Co. (MSD) Recent Developments
Table 56. Novartis Basic Information List
Table 57. Novartis Description and Business Overview
Table 58. Novartis Patent Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Patent Drug Business of Novartis (2020-2025)
Table 60. Novartis Recent Developments
Table 61. AbbVie Basic Information List
Table 62. AbbVie Description and Business Overview
Table 63. AbbVie Patent Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Patent Drug Business of AbbVie (2020-2025)
Table 65. AbbVie Recent Developments
Table 66. Gilead Sciences Basic Information List
Table 67. Gilead Sciences Description and Business Overview
Table 68. Gilead Sciences Patent Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Patent Drug Business of Gilead Sciences (2020-2025)
Table 70. Gilead Sciences Recent Developments
Table 71. GlaxoSmithKline (GSK) Basic Information List
Table 72. GlaxoSmithKline (GSK) Description and Business Overview
Table 73. GlaxoSmithKline (GSK) Patent Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Patent Drug Business of GlaxoSmithKline (GSK) (2020-2025)
Table 75. GlaxoSmithKline (GSK) Recent Developments
Table 76. Amgen Basic Information List
Table 77. Amgen Description and Business Overview
Table 78. Amgen Patent Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Patent Drug Business of Amgen (2020-2025)
Table 80. Amgen Recent Developments
Table 81. AstraZeneca Basic Information List
Table 82. AstraZeneca Description and Business Overview
Table 83. AstraZeneca Patent Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Patent Drug Business of AstraZeneca (2020-2025)
Table 85. AstraZeneca Recent Developments
Table 86. Bristol-Myers Squibb Basic Information List
Table 87. Bristol-Myers Squibb Description and Business Overview
Table 88. Bristol-Myers Squibb Patent Drug Products, Services and Solutions
Table 89. Revenue (US$ Million) in Patent Drug Business of Bristol-Myers Squibb (2020-2025)
Table 90. Bristol-Myers Squibb Recent Developments
Table 91. Eli Lilly Basic Information List
Table 92. Eli Lilly Description and Business Overview
Table 93. Eli Lilly Patent Drug Products, Services and Solutions
Table 94. Revenue (US$ Million) in Patent Drug Business of Eli Lilly (2020-2025)
Table 95. Eli Lilly Recent Developments
Table 96. Teva Basic Information List
Table 97. Teva Description and Business Overview
Table 98. Teva Patent Drug Products, Services and Solutions
Table 99. Revenue (US$ Million) in Patent Drug Business of Teva (2020-2025)
Table 100. Teva Recent Developments
Table 101. Bayer Basic Information List
Table 102. Bayer Description and Business Overview
Table 103. Bayer Patent Drug Products, Services and Solutions
Table 104. Revenue (US$ Million) in Patent Drug Business of Bayer (2020-2025)
Table 105. Bayer Recent Developments
Table 106. Novo Nordisk Basic Information List
Table 107. Novo Nordisk Description and Business Overview
Table 108. Novo Nordisk Patent Drug Products, Services and Solutions
Table 109. Revenue (US$ Million) in Patent Drug Business of Novo Nordisk (2020-2025)
Table 110. Novo Nordisk Recent Developments
Table 111. AbbVie Basic Information List
Table 112. AbbVie Description and Business Overview
Table 113. AbbVie Patent Drug Products, Services and Solutions
Table 114. Revenue (US$ Million) in Patent Drug Business of AbbVie (2020-2025)
Table 115. AbbVie Recent Developments
Table 116. Takeda Basic Information List
Table 117. Takeda Description and Business Overview
Table 118. Takeda Patent Drug Products, Services and Solutions
Table 119. Revenue (US$ Million) in Patent Drug Business of Takeda (2020-2025)
Table 120. Takeda Recent Developments
Table 121. Boehringer Ingelheim Basic Information List
Table 122. Boehringer Ingelheim Description and Business Overview
Table 123. Boehringer Ingelheim Patent Drug Products, Services and Solutions
Table 124. Revenue (US$ Million) in Patent Drug Business of Boehringer Ingelheim (2020-2025)
Table 125. Boehringer Ingelheim Recent Developments
Table 126. Takeda Basic Information List
Table 127. Takeda Description and Business Overview
Table 128. Takeda Patent Drug Products, Services and Solutions
Table 129. Revenue (US$ Million) in Patent Drug Business of Takeda (2020-2025)
Table 130. Takeda Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Patent Drug Downstream Customers
Table 134. Patent Drug Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Patent Drug Product Picture
Figure 2. Global Patent Drug Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Patent Drug Sales Value (2020-2031) & (US$ Million)
Figure 4. Patent Drug Report Years Considered
Figure 5. Global Patent Drug Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Patent Drug Revenue in 2024
Figure 7. Patent Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Oral Picture
Figure 9. Injection Picture
Figure 10. Other Picture
Figure 11. Global Patent Drug Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global Patent Drug Sales Value Market Share by Type, 2024 & 2031
Figure 13. Product Picture of Hospital
Figure 14. Product Picture of Retail Pharmacy
Figure 15. Global Patent Drug Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Patent Drug Sales Value Market Share by Application, 2024 & 2031
Figure 17. North America Patent Drug Sales Value (2020-2031) & (US$ Million)
Figure 18. North America Patent Drug Sales Value by Country (%), 2024 VS 2031
Figure 19. Europe Patent Drug Sales Value, (2020-2031) & (US$ Million)
Figure 20. Europe Patent Drug Sales Value by Country (%), 2024 VS 2031
Figure 21. Asia Pacific Patent Drug Sales Value, (2020-2031) & (US$ Million)
Figure 22. Asia Pacific Patent Drug Sales Value by Region (%), 2024 VS 2031
Figure 23. South America Patent Drug Sales Value, (2020-2031) & (US$ Million)
Figure 24. South America Patent Drug Sales Value by Country (%), 2024 VS 2031
Figure 25. Middle East & Africa Patent Drug Sales Value, (2020-2031) & (US$ Million)
Figure 26. Middle East & Africa Patent Drug Sales Value by Country (%), 2024 VS 2031
Figure 27. Key Countries/Regions Patent Drug Sales Value (%), (2020-2031)
Figure 28. United States Patent Drug Sales Value, (2020-2031) & (US$ Million)
Figure 29. United States Patent Drug Sales Value by Type (%), 2024 VS 2031
Figure 30. United States Patent Drug Sales Value by Application (%), 2024 VS 2031
Figure 31. Europe Patent Drug Sales Value, (2020-2031) & (US$ Million)
Figure 32. Europe Patent Drug Sales Value by Type (%), 2024 VS 2031
Figure 33. Europe Patent Drug Sales Value by Application (%), 2024 VS 2031
Figure 34. China Patent Drug Sales Value, (2020-2031) & (US$ Million)
Figure 35. China Patent Drug Sales Value by Type (%), 2024 VS 2031
Figure 36. China Patent Drug Sales Value by Application (%), 2024 VS 2031
Figure 37. Japan Patent Drug Sales Value, (2020-2031) & (US$ Million)
Figure 38. Japan Patent Drug Sales Value by Type (%), 2024 VS 2031
Figure 39. Japan Patent Drug Sales Value by Application (%), 2024 VS 2031
Figure 40. South Korea Patent Drug Sales Value, (2020-2031) & (US$ Million)
Figure 41. South Korea Patent Drug Sales Value by Type (%), 2024 VS 2031
Figure 42. South Korea Patent Drug Sales Value by Application (%), 2024 VS 2031
Figure 43. Southeast Asia Patent Drug Sales Value, (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Patent Drug Sales Value by Type (%), 2024 VS 2031
Figure 45. Southeast Asia Patent Drug Sales Value by Application (%), 2024 VS 2031
Figure 46. India Patent Drug Sales Value, (2020-2031) & (US$ Million)
Figure 47. India Patent Drug Sales Value by Type (%), 2024 VS 2031
Figure 48. India Patent Drug Sales Value by Application (%), 2024 VS 2031
Figure 49. Patent Drug Industrial Chain
Figure 50. Patent Drug Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
